Bambusa Therapeutics Appoints Todd James Chief Financial Officer
- Written by PR Newswire
- Mr. James brings more than 20 years of biopharmaceutical leadership experience, with deep expertise in capital markets, investor relations, and corporate strategy, serving in senior executive roles at Acceleron Pharma prior to its $11.5 billion acquisition by Merck and at Viridian Therapeutics -
BOSTON, March 19, 2026 /PRNewswire/ -- Bambusa...
Read more: Bambusa Therapeutics Appoints Todd James Chief Financial Officer














